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Abstract
Background: Sleep disturbances are widespread among nursing home (NH) patients and associated with
numerous negative consequences. Identifying and treating them should therefore be of high clinical priority.
No prior studies have investigated the degree to which sleep disturbances as detected by actigraphy and by
the sleep-related items in the Cornell Scale for Depression in Dementia (CSDD) and the Neuropsychiatric Inventory –
Nursing Home version (NPI-NH) provide comparable results. Such knowledge is highly needed, since both
questionnaires are used in clinical settings and studies use the NPI-NH sleep item to measure sleep disturbances.
For this reason, insight into their relative (dis)advantages is valuable.
Method: Cross-sectional study of 83 NH patients. Sleep was objectively measured with actigraphy for 7 days, and
rated by NH staff with the sleep items in the CSDD and the NPI-NH, and results were compared. McNemar's tests
were conducted to investigate whether there were significant differences between the pairs of relevant measures.
Cohen's Kappa tests were used to investigate the degree of agreement between the pairs of relevant actigraphy,
NPI-NH and CSDD measures. Sensitivity and specificity analyses were conducted for each of the pairs, and receiver
operating characteristics (ROC) curves were designed as a plot of the true positive rate against the false positive
rate for the diagnostic test.
Results: Proxy-raters reported sleep disturbances in 20.5% of patients assessed with NPI-NH and 18.1% (difficulty
falling asleep), 43.4% (multiple awakenings) and 3.6% (early morning awakenings) of patients had sleep
disturbances assessed with CSDD. Our results showed significant differences (p<0.001) between actigraphy
measures and proxy-rated sleep by the NPI-NH and CSDD. Sensitivity and specificity analyses supported these
results.
Conclusions: Compared to actigraphy, proxy-raters clearly underreported NH patients' sleep disturbances as
assessed by sleep items in NPI-NH and CSDD. The results suggest that the usefulness of proxy-rater measures
of sleep may be questionable and further research is needed into their clinical value. The results highlight the
need for NH staff to acquire and act on knowledge about sleep and sleep challenges among NH patients.
Trial registration: Registered at www.clinicaltrials.gov (registration number NCT02238652) on July 7th 2014
(6 months after study initiation).
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Background
In nursing homes (NH), wherein approximately 50–80%
of patients have dementia [1–4], sleep disturbances are
widespread and severe [5]. Advanced age is associated
with a decrease in total sleep time [5], slow-wave sleep
and rapid eye movement (REM) sleep [6]. Moreover, ap-
proximately 60% experience sleep disturbances at night-
time [7]. Disturbed sleep is associated with multiple
negative consequences and predicts an increased risk of
developing depression among the elderly [8]. Previous
studies have shown that disturbed sleep may lead to re-
duced quality of life and impaired cognitive daytime
functioning in elderly people with and without dementia
[9, 10]. As argued by Flo et al. [11], these outcomes may
be especially important for the elderly, since such symp-
toms may be misinterpreted as dementia or more severe
dementia. Since so many institutionalized patients are
affected by dementia, the consequence may be that they
often are no longer able to give valid self-report, a pre-
requisite for adequate symptom assessment and treatment
[12]. Therefore, they depend on the ability of health care
professionals to evaluate and treat their distressing symp-
toms, including sleep disturbances.
Identifying and treating sleep disturbances in this fragile
and multimorbid group should be of high clinical priority.
However, evaluating sleep in NH patients with dementia
is a methodological challenge [13]. Meanwhile, most tools
rely primarily on interviewing NH staff members, who
function as proxy-raters for the patients. This renders the
reliability of such measurement uncertain [14], while their
relatively low cost and effort in use, make them attractive
in the clinical setting.
Wrist-worn actigraphic recordings are considered the
most reliable instrument for objectively measuring
sleep in this patient group [15, 16]. However, there is a
high cost associated with the use of such equipment.
Most et al. [17] compared the subjective assessments
tools Pittsburgh Sleep Quality Index, Sleep Disorders
Questionnaire, Athens Insomnia Scale and actigraphy.
The study showed that the value of sleep questionnaires
is limited in early and moderate stage Alzheimer dis-
ease and recommended actigraphy as a supplement in
detecting sleep disturbances. Meanwhile, Tractenberg
et al. [18] showed that scores from the Sleep Disorders
Inventory (SDI) correlated with actigraphy data, except
for 24-h total sleep time and daytime total sleep time.
Hoekert et al. [19] similarly found a high degree of cor-
relation between actigraphy and measures in the Sleep
Inventory for Normal and Pathological States. However,
the assessment tools mentioned above are not routinely
used in NH settings to assess sleep. Thus, it is of high
importance to investigate the accuracy of proxy-rater
tools that are commonly used in both the research set-
ting and the clinical setting, and the relative advantages
and disadvantages of actigraphy and proxy-rater tools,
respectively.
To our knowledge, no prior studies have investigated
the relationship between clinically significant sleep
disturbances as detected by actigraphy and by the sleep-
related items in the Cornell Scale for Depression in
Dementia (CSDD) and the Neuropsychiatric Inventory –
Nursing Home version (NPI-NH), respectively. This is
highly needed, since both of the questionnaires are used
in clinical settings and several studies use the NPI-NH
sleep item to measure sleep disturbances among NH pa-
tients [20–23].
Consequently, the aim of this study was to investigate
the degree to which actigraphy-based and proxy-rater-
based assessments of sleep in NH patients provided com-
parable clinical outcomes. This allows for an assessment
of their relative advantages and disadvantages. The study
thus provides insight into similarities and differences in
the measurement of sleep disturbances by means of these
two approaches, which may provide crucial information
for future clinical assessment procedures and research.
Methods
Design and setting of the study
The present study was based on baseline data from the
COSMOS trial [24]; a 4-month cluster-randomized and
controlled effectiveness-implementation hybrid trial
with follow-up at month 9. The study was conducted in
Norway from January 2014 to December 2015. To gain
a representative distribution of NHs, urban/rural and
big/small municipalities were invited. NH patients
≥65 years old, with and without dementia, with life ex-
pectancy >6 months, not diagnosed with schizophrenia,
were eligible for inclusion. Patients with any form of
chronic movement disorder or any form of paralysis in
the arms/upper body were excluded from the actigra-
phy registrations.
Measurements
At baseline, a research team responsible for the COSMOS
trial informed and supervised NH staff in the different
assessment tools. Only NH staff members who knew the
patients were asked to partake in the assessment. Socio-
demographic variables were collected from patients’
medical records.
Sleep was objectively assessed using the Actiwatch
Spectrum (Philips Respironics). Since NH patients are
quite inactive, the actigraphs were placed on the pa-
tients’ dominant/mobile wrist to increase the possibility
of detecting movement. Previous studies have found no
difference between data collected from actigraphs
placed on different locations [25, 26]. NH staff was
instructed to push the event button at bed and rise
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times (light off in the night/light on in the morning),
both by verbal and written instruction.
We used the following scoring protocols: rest inter-
vals were set using a standardized hierarchical approach
based on (1) event markers, (2) light and activity data,
and (3) light or activity data. To ensure inter-scorer re-
liability, 30 of the actigraphy recordings were scored
twice by two independent scorers, and compared in
terms of total time in bed and total sleep time. To be
included, participants would have to complete at least
five night recordings. Sleep/wake status was determined
for each one-minute epoch using the Actiware 6
(Respironics) scoring program and validated algorithm,
with the sensitivity set to medium. The scoring was
used to generate the following variables: sleep onset
latency (SOL), wake after sleep onset (WASO), early
morning awakening (EMA), number of wake bouts
(NoW),
To define disturbed sleep in this population we
followed the quantifiable criteria described in the DSM-
5 diagnostic features for insomnia [27]. Hence, we used
the following cut-off points to define sleep disturbances
as measured with actigraphy: SOL >30 min; WASO
>30 min; EMA > 30 min. In addition, we used NoW ≥3.
In accordance with Lacks and Morin [28], we used a
cut-off of <85% for sleep efficiency, i.e. time spent asleep
divided by time spent in bed [13].
Sleep was subjectively assessed with the NPI-NH,
which is a proxy-rater inventory assessing twelve
neuropsychiatric symptoms associated with dementia
[29]. In the present study, we used item 11 – nighttime
behavior – to ascertain sleep disturbances as observed
and judged by proxy-raters. Proxy-raters were guided
by questions formulated as follows: “Does the patient
have sleep problems? Is s/he awake during the night?
Does s/he wander during night-time, getting dressed, or
going into the room of others?” Each symptom was
scored for frequency (score 1–4) and severity (score 1–3),
subsequently a product score was calculated thereof. In
line with Garcia-Alberca et al. [20] and Chwiszczuk et al.
[23], we used a product score ≥ 4 as a cut-off to define the
presence of sleep disturbances.
Sleep was also assessed by the CSDD, a proxy-rater in-
strument for the measurement of depression, which is
validated both for people with and without dementia
[30–32]. Questions regarding sleep fall under the cat-
egory of “cyclic functions” and comprise item 13 (“Does
the patient have difficulty falling asleep?”), item 14
(“Does the patient have multiple awakenings during
sleep?”) and item 15 (“Does the patient have early morn-
ing awakenings?”). For item 13, a score of 1 was given if
the patient only had difficulty falling asleep a few nights
in the past week and 2 if there was difficulty every night.
For item 14, the patient was given a score of 1 if sleep
was restless and occasionally disturbed. If the patient
got out of bed in the middle of the night and/or had
woken up every night in the past week, a score of 2 was
given. For item 15, a score of 1 was given if the patient
woke up early, but then went back to sleep. A score of
2 was given if the patient woke up earlier than usual
and could not go back to sleep. A cut-off score of ≥1
was used to define sleep disturbances identified by
proxy-raters for item 13 and 14. For item 15 a cut-off
score of 2 was used. Item 13 was used as a measure of
problems with SOL, item 14 as a measure of NoW, and
item 15 as a measure of EMA, in the comparisons be-
tween the CSDD items and actigraphy measurements.
The rating is in line with the guidelines by Alexopoulos
et al. [30].
Cognitive function was assessed by the Mini Mental
State Examination (MMSE), which is a 30-point validated
scale that consists of 20 tasks. Scores from 0 to 10 indicate
severe impairment, 11 to 20 is consistent with moderate
impairment, 21 to 25 is consistent with mild impairment,
and scores of 26 to 30 suggest no impairment [33, 34].
Statistical analyses
Descriptive statistics were calculated for all relevant
variables. McNemar’s tests were conducted to investi-
gate whether or not there were significant differences
between the pairs of relevant measures. Cohen’s Kappa
tests were used to investigate the degree of agreement
between the pairs of relevant actigraphy, NPI-NH and
CSDD variables. Sensitivity and specificity analyses
were also conducted for each of the pairs of measures.
Furthermore, receiver operating characteristics (ROC)
curves were calculated, as a plot of the true positive
rate against the false positive rate for the diagnostic
test. The AUC values of the ROC curves serve to evalu-
ate the performance for each of the pairs of measures.
AUC values can be assessed as follows: a value of 1 sig-
nifies a perfect test, a value of 0.97 signifies a very good
test, values below 0.75 are not considered clinically
useful, and values close to 0.5 have no discriminatory
value at all [35].
The actigraphy measures were chosen as the reference
standard and the analyses measured the degree to which
the CSDD and NPI-NH measures captured the same as
did the actigraphy measures. To test whether the final
actigraphy sample (n = 83) differed systematically from
the remainder of the study sample (n = 462), we con-
ducted independent samples t-tests comparing the mean
scores of the two samples for the following variables:
age, sex, MMSE score, CSDD scores (difficulty falling
asleep; early morning awakening; multiple awakenings)
and NPI-NH score (sleep item). We conducted the
statistical analyses using IBM SPSS Statistics 22.
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Ethics
Informed written consent was obtained through direct
conversation with patients. If the patient lacked the ability
to give consent, we obtained it through direct conversa-
tion with the patient’s legal guardian. The legal guardian
gave presumed consent on behalf of the patient. This is in
line with local legislation. The trial was approved by the
Regional Committee for Medical and Health Research
Ethics, West Norway (REK 2013/1765) and registered at
www.clinicaltrials.gov (NCT02238652).
Results
A total of 700 NH patients were invited to participate
in the COSMOS study, of which 545 participants from
67 NH units were included. The first 10 patients in
every NH unit were evaluated for inclusion in the acti-
graph subproject. The actigraphy subproject included
107 patients, 24 of whom were excluded due to acti-
graph malfunction or because of missing data. The final
sample thus included 83 patients who wore actigraphs
and had complete CSDD and NPI-NH scores. For the
variables outlined above, there were no statistically sig-
nificant differences between the scores for the actigra-
phy sample and the remainder of the study sample.
Patient characteristics are summarized in Table 1.
Sleep disturbances in NH patients as assessed by
actigraphy
The mean number of actigraphy-registered nights per
patient was 6.6 (SD = 1.1). Mean time spent in bed was
12 h and 20 min (SD = 1 h 43 min). Mean sleep effi-
ciency was 64.1% (SD = 19.2), and 89.2% of the patients
had sleep efficiency <85%. Mean SOL was 57.9 min
(SD = 80.1) and 45.8% had SOL >30 min. Mean WASO
was 151.8 min (SD = 80.2), i.e. approximately 2.5 h, and
97.6% had WASO >30 min. Mean EMA was 54.5 min
(SD = 66.5), and 59.0% of the patients had EMA > 30 min.
Mean NoW was 32.1 (SD = 13.4), with a mean length of
5.1 min (SD = 3.1). All actigraphy results are summa-
rized in Table 2.
Sleep disturbances assessed with NPI-NH compared with
actigraphy
Proxy-raters reported sleep disturbances in 20.5% of pa-
tients assessed with NPI-NH. McNemar’s test comparing
sleep efficiency measured with actigraphy and proxy-
rater sleep (NPI-NH-SS ≥ 4) showed a significant differ-
ence (p < 0.001) between the measures (see Table 3).
This was supported by the Cohen’s Kappa analysis,
which showed very low agreement between the measures
(k = .029).
In the NPI-NH measurements, we found one false
positive (i.e. instances where proxy-raters reported
sleep disturbances when actigraphy did not) and 57
false negatives (i.e. instances where proxy-raters did not
report sleep disturbances when actigraphy did). Com-
pared with the sleep efficiency measure, the sensitivity
of the NPI-NH proxy-rater sleep measure was 21.9%
(95% CI = 13.4% - 33.4%). The specificity of the meas-
ure was 88.9% (95% CI = 50.7% - 99.4%). Thus, the
positive likelihood ratio of the test was 1.97, while the
negative likelihood ratio of the test was 0.88. The AUC
value of the ROC curve was 0.554.
Sleep disturbances assessed with CSDD compared with
actigraphy
McNemar’s test for actigraphy SOL >30 min (45.8%) and
the CSDD “difficulty falling asleep” (18.1%) item showed
a significant difference (p < 0.001) between the measures
Table 1 The table shows descriptive statistics on prevalence
(mean values and standard deviations) for socio-demographic
variables, NPI-NH1 sum score = Neuropsychiatric Inventory –
Nursing Home version, CSDD2 = Cornell Scale for Depression in
Dementia. MMSE3 = Mini Mental State Examination. SD = standard
deviation
Descriptive statistics (n = 83)
Age (mean, SD) 86.6 (8.1)
Female (percentage) 75.9% (n = 63)
CSDD2 sum score (mean, SD) 6.0 (5.9)
MMSE3 sum score (mean, SD) 10.4 (7.5)
MMSE score 20 or below (number, percentage) 59 (86.8%)
MMSE score > 20 (number, percentage) 9 (13.2%)
Number of medications (mean, SD) 7.5 (3.7)
Table 2 Actigraphically measured sleep parameters, mean values
with standard deviations
Sleep parameters (n = 83)
Time spent in bed (hours:min), mean (SD) 12:20 (1:43)
Observation nights, mean (SD) 6.6 (1.0)
Sleep efficiency (%), mean (SD) 64.1 (19.2)
Sleep efficiency below 85% 89.2% (n = 74)
SOL (min), mean (SD) 57.9 (80.1)
Patients with SOL above 30 min 45.8% (n = 38)
WASO (min), mean (SD) 151.8 (80.2)
WASO above 30 min 97.6% (n = 81)
EMA (min), mean (SD) 54.5 (66.5)
EMA above 30 min 59.0% (n = 49)
NoW mean (SD) 32.1 (13.4)
NoW equal or above 3 98.8% (n = 82)
Length of wake bouts (min), mean (SD) 5.1 (3.1)
Bedtime (hours:min), mean (SD) 20:20 (2.21)
Wake up time (hours:min), mean (SD) 8:57 (1:29)
SOL refers to sleep onset latency. WASO refers to wake after sleep onset. EMA
refers to early morning awakening. NoW refers to the number of wake bouts
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(see Table 3). This was supported by the Cohen’s Kappa
analysis, which showed very low agreement between the
measures (k = .105). In the CSDD SOL measurements,
there were six false positives and 29 false negatives.
Compared with the actigraphy measure, the sensitivity
of the CSDD “difficulty falling asleep” measure was
23.7% (95% CI = 12.0% - 40.6%). The specificity of the
CSDD was 86.4% (95% CI = 72.0% - 94.3%). Thus, the
positive likelihood ratio of the test was 1.74, while the
negative likelihood ratio of the test was 0.88. The AUC
value of the ROC curve was 0.550.
McNemar’s test comparing EMA > 30 min measured
with actigraphy (59%) and the CSDD “does the patient
have early morning awakenings?” (EMA) item (3.6%)
showed a significant difference (p < 0.001) between the
measures (see Table 3). This was supported by the
Cohen’s Kappa analysis, which showed very low agree-
ment between the measures (k = .051). In the CSDD
EMA measurements, there were no false positives, but
46 false negatives. Compared with the actigraphy meas-
ure, the sensitivity of the CSDD EMA measure was
6.1% (95% CI = 1.59% - 17.9%). The specificity of the
measure was 100% (95% CI = 87.4% - 100%). Thus, the
positive likelihood ratio of the test cannot be calculated,
while the negative likelihood ratio of the test was 0.94.
The AUC value of the ROC curve was 0.531.
McNemar’s test comparing NoW ≥3 measured with
actigraphy (98.8%) and CSDD “multiple awakenings dur-
ing sleep” item (43.4%) showed a significant difference
(p < 0.001) between the measures (see Table 3). This was
supported by the Cohen’s Kappa analysis, which showed
a very low agreement between the measures (k = .019).
In the CSDD NoW measurements, there were no false
positives, but 45 false negatives. Compared with the
NoW as measured by actigraphy, the sensitivity of the
CSDD “multiple awakenings during sleep” measure was
44.4% (95% CI = 33.5% - 55.9%). The specificity of the
measure was not possible to calculate, due to the low
number of observations. Thus, the positive likelihood ra-
tio cannot be calculated, but the negative likelihood ratio
of the test was 0.56. The AUC value of the ROC curve
was 0.722.
Discussion
The aim of this study was to investigate the degree to
which actigraphy-based and common proxy-rater-based
assessments of sleep in NH patients provided compar-
able clinical outcomes. This allows for an assessment of
their relative merits, when the costs, efforts and benefits
of their use are taken into account. Taken together, the
analyses (McNemar’s test, Cohen’s Kappa and sensitiv-
ity/specificity analyses, all of which are reported in Table
3) revealed that there were highly significant differences
(p < 0.001) between the measures with respect to their
ability to capture the various sleep outcomes (SOL,
EMA and NoW). The Cohen’s Kappa values suggested
low degrees of agreement between the measures for all
pairs of variables. This was also supported by the sensi-
tivity, specificity and likelihood ratio analyses, and the
corresponding ROC-curves. The results overall revealed
that the CSDD and NPI-NH measures had from very
small to small probability for capturing the sleep out-
comes detected by actigraphic recordings. This is of key
importance since it implies that sleep disturbances may
go undetected and thereby untreated among NH pa-
tients. These results should be viewed in the context of
the nature of the two measures: While actigraphy in-
volves the use of equipment which implies relatively
high cost in use, proxy-rater tools are used mostly for
screening purposes with low cost and effort.
Using NPI-NH, staff categorized 20.5% of the patients
as having sleep disturbances. This was significantly
lower than the objective actigraphy measure of sleep,
by which 89.2% had sleep efficiency below 85%. Since
the study included both patients with and without
dementia, it is important to notice that the NPI-NH
was developed for use among people with dementia.
However, in the total sample, 87% of patients had an
MMSE score < 20, which is compatible with dementia
[34]. Only 13% had an MMSE score > 20, and the mean
MMSE score in this sub-group was 23.6. Based on this,
we can assume that most of the patients in the total
sample have mild cognitive impairment or dementia.
For this reason, we have included the NPI-NH scores
of all patients in the present study. Comparing sleep
Table 3 Significant differences between actigraphy measured wrist activity compared to percentages of patients’ sleep outcome
measured with proxy-rated CSDD and NPI-NH
Actigraphy CSDD NPI-NH p k
SOL above 30 min or CSDD-DFA ≥ 1 45.8% (n = 38) 18.1% (n = 15) <0.001 .105
EMA above 30 min or CSDD-EMA ≥ 2 59.0% (n = 49) 3.6% (n = 3) <0.001 .051
NoW ≥3 or CSDD-MA ≥ 1 98.8% (n = 82) 43.4% (n = 36) <0.001 .019
SE below 85% or NPI-NH-SS ≥ 4 89.2% (n = 74) 20.5% (n = 17) <0.001 .029
SOL refers to the Sleep Onset Latency measure using actigraphy. EMA refers to the Early Morning Awakening measure. NoW refers to the Number of Wake Bouts
measure. SE refers to the Sleep Efficiency measure. CSDD-DFA refers to the Difficulty Falling Asleep measure in the Cornell Scale for Depression in Dementia
(CSDD). CSDD-EMA refers to the Early Morning Awakening measure in the CSDD. CSDD-MA refers to the Multiple Awakenings measure in the CSDD. NPI-NH-SS re-
fers to the Subjective Sleep measure in the Neuropsychiatric Inventory – Nursing Home version. k = Cohen’s Kappa
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efficiency with the NPI-NH sleep item is not optimal,
since sleep efficiency is a measure of time spent asleep
divided by time spent in bed, while the NPI-NH more
broadly captures general sleep disturbances. However,
sleep efficiency is often used as an indicator of sleep qual-
ity [36, 37]. Thus, it can be argued that the sleep item in
NPI-NH to some extent should capture sleep quality and/
or disturbances. The excessive time in bed reported in our
study, which is an important determinant for the calcula-
tion of sleep efficiency, is in accordance with previous
studies [13, 16].
Actigraphy detected significantly more sleep distur-
bances relating to SOL, NoW and EMA than did CSDD
sleep items. These results thus also indicate that NH
staff underreport or do not recognize patients’ sleep dif-
ficulties, as captured by actigraphy. In contrast, Fetveit
and Bjorvatn [13] found that NH staff observations
(diaries) of SOL and EMA were consistent with acti-
graphic recordings. However, the way these parameters
are measured is not comparable with the measurements
of the present study. NH staff diaries are based on obser-
vation during a given period, and the observation is
recorded in writing. It is noteworthy, however, that
nocturnal awakenings registered by NH staff in the study
by Fetveit and Bjorvatn [13] showed little correlation
with actigraphy-recorded WASO. This is in line with the
present findings, which also indicated that NH staff
noticed fewer awakenings compared with actigraphy.
Is the divergence between the actigraphy recordings
and proxy-rater assessments due to the raters or due to
the rating instruments? A potential reason could be lack
of knowledge about sleep among NH staff. This could in
turn result in lower perceptiveness in recognizing sleep
disturbances. In addition, the proxy-raters were not ne-
cessarily night workers. It is possible that observations
from night workers were not properly conveyed to the
day shift staff. Furthermore, many patients in Norwegian
NHs lie in bed during night-time with the cot side of the
bed in the upward position. The consequence is that
many patients are unable to exit the bed at night. Com-
bined with a reduced capacity for verbal expression due
to dementia, this may reduce their interaction with the
night shift workers, which could lead to an impression
of sleeping even when patients might be awake.
In line with previous research, the results of the present
study showed that sleep disturbances are very common
among NH patients. Interestingly, the findings indicate
that sleep disturbances as measured with actigraphy are
even more prevalent now than what was found in earlier
studies. Fetveit and Bjorvatn [13] found mean sleep effi-
ciency of 75% among NH patients, with 72% of the pa-
tients displaying sleep efficiency below 85%. A pioneering
study by Ancoli-Israel et al. [38] found that patients on
average slept 39.5 min per hour in any hour of the night,
and 50% woke up 2 to 3 times per hour. The patients in
the present study displayed a mean sleep efficiency of 64%
and as many as 89.2% of the patients had sleep efficiency
below 85%.
It is beyond the scope of this study to explore the
discrepancy between results regarding actigraphy sleep
parameters herein and results from earlier studies.
However, a recent report shows that the proportion of
NH patients with comprehensive assistance needs has
increased from 2009 to 2015. This suggests that the
NH population is generally in poorer condition now
than earlier [39]. This is notable since previous studies
have shown that a decreased ability to sleep is associ-
ated with comorbidities [40]. This development may
potentially explain some of the discrepancy between
prior studies and the present study.
The sample size of 83 patients with actigraphy assess-
ment in the present study is larger than previous stud-
ies using actigraphy to assess sleep in this population
[13, 16, 41, 42]. The low agreement between actigraphy
and proxy-rater measures may simply indicate that the
CSDD and the NPI-NH fail to capture sleep difficulties.
In light of recent research that indicates that when the
CSDD is administered by NH staff, its clinical utility is
highly questionable, the discrepancy found in the present
study also questions the use of proxy-raters to ascertain
symptoms [43]. However, it is noteworthy that we do not
recommend actigraphy as the primary tool for evaluating
sleep in the NH setting. This would arguably be costly and
time consuming, and thus not feasible as a screening tool.
However, the results are suggestive of a need for more
precise instruments for measuring sleep among NH pa-
tients, which could be used in a low-cost and valid man-
ner by proxy-raters.
Limitations
Previous studies indicate that actigraphy is less accurate in
distinguishing sleep from wakefulness when sleep effi-
ciency is reduced [22, 35]. Therefore, actigraphy recor-
dings may overestimate sleep relative to sleep diaries and
polysomnography [44, 45]. Taking this into consideration,
the total amount of sleep may be less and even more frag-
mented than what is suggested by the results from the
present study. This means that the sensitivity for sleep in
the NPI-NH and CSDD may be even lower than estimated
herein. Meanwhile, polysomnography is not an optimal
form for assessing sleep in this patient population. It is
difficult to score since electroencephalography does not
produce clear patterns of sleep stages in demented pa-
tients [15]. Secondly, there is a low tolerance in this group
for wearing such equipment [13]. Actigraphy is therefore
considered the best method for assessing sleep objectively
in this population [15, 16].
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Conclusion
The study revealed that when sleep was measured with
common clinical tools like NPI-NH and CSDD, sleep dis-
turbances were clearly underreported or unrecognized by
NH staff as compared with actigraphy. The results thus
suggest that the usefulness of proxy-rater measures of
sleep may be questionable and further research is needed
into its clinical value. Our results do not allow us to con-
clude whether the divergence in results are due to the
raters or the rating instruments. However, in order to en-
able NH staff to treat sleep disturbances, the first step is
to identify that the patient has a problem. The results
therefore highlight the need for NH staff to acquire and
act on knowledge about sleep and potential sleep chal-
lenges in the population of NH patients, which in turn
may increase the likelihood for adequate treatment.
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